Tesla: TSLA
Tesla's stock price has been on a rip since the election. A cynic would say that since Elon Musk has President Trump's ear, Tesla will get some subsidies and/or regulatory…
Year End Review
No question about it. 2024 was a good year for investors and traders willing to move out along the risk curve. This article is for registered members - please login…
Range Resources: RRC
The natural gas market is finally waking up. We have been wondering when that will happen as the need for electricity is growing rapidly, and the fuel of choice in…
Macro Analysis
As the year ends, we like to look at the big picture to see how we might want to position trades in the early part of the upcoming year. This…
Close a few more trades.
As we approach year-end, we notice that stock prices are having trouble. US Treasury yields are rising (bond prices are falling), and we think this has something to do with…
Going to the Dogs (part 3)
As the final installment of our 3 part “Dogs of the Dow/S&P 500” series of articles, we’re following up on Monday’s trade idea in ConocoPhillips, an idea for an “oil”…
Going to the Dogs (part 2)
In the prior article, we discussed the “Dogs of the Dow (and S&P 500)” investment strategies, in which investors rank the stocks in the respective indices by their dividend yield…
The Dog Days of Winter…
The "Dogs of the Dow" and the slightly less well-known “Dogs of the S&P” are stock-picking strategies focused on the Dow Jones Industrial Average (DJIA) and S&P 500. At the…
Healthcare Expenditures Keep Rising, So What Ails the Sector?
This article is for paid members - please login or subscribe for access.
GSK PLC: GSK
GSK is a global player in the category of ethical drugs. This article is for paid members - please login or subscribe for access.
Jerome Powell didn’t deal us a great hand, but don’t fold yet…
This article is for paid members - please login or subscribe for access.